Cantor Fitzgerald analyst Steven Halper raised his price target for Anthem to $330 after management said in investor meetings that it will use $3.2B from its pharmacy benefit manager savings beginning in 2020 and 2021 to drive membership growth in subsequent years. Accordingly, the analyst increased his top-line growth assumptions. He expects membership and revenue to grow faster without sacrificing margins and keeps an Overweight rating on Anthem.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.